Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito?s classes. People and many animals may be infection source after infection Encephalitis virus.
Encephalitis Vaccination Market aims to provide a comprehensive presentation of the global market for Encephalitis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Encephalitis Vaccination. Encephalitis Vaccination Market contains market size and forecasts of Encephalitis Vaccination in global, including the following market information:
- Global Encephalitis Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Encephalitis Vaccination Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Encephalitis Vaccination companies in 2022 (%)
The global Encephalitis Vaccination market was valued at US$ 1328.6 million in 2022 and is projected to reach US$ 1914.7 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
We surveyed the Encephalitis Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Encephalitis Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Encephalitis Vaccination Market Segment Percentages, by Type, 2022 (%)
- Encephalitis B Vaccine
- Encephalitis Attenuated Live Vaccine
Global Encephalitis Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Encephalitis Vaccination Market Segment Percentages, by Application, 2022 (%)
Public Hospital
- Private Hospital
- Clinic
- Other
Global Encephalitis Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Encephalitis Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Encephalitis Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Encephalitis Vaccination revenues share in global market, 2022 (%)
- Key companies Encephalitis Vaccination sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Encephalitis Vaccination sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- Sanofi
- Chengdu Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- Beijing Taitan
- Valneva
- Bharat Biotech
- Liaoning Chengda
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Encephalitis Vaccination, market overview.
- Chapter 2: Global Encephalitis Vaccination market size in revenue and volume.
- Chapter 3: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Encephalitis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Encephalitis Vaccination capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
Industry Market Size
